Impact of the COVID-19 Pandemic on Antibiotic Prescribing for Common Infections in the Netherlands: A Primary Care-Based Observational Cohort Study
| Autor: | Marlous F Kortekaas, Josi A Boeijen, Alike W van der Velden, Roger A M J Damoiseaux, Roderick P Venekamp, Alma C van de Pol, Tamara N Platteel |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Microbiology (medical)
Mastoiditis medicine.medical_specialty complications medicine.drug_class infectious disease respiratory tract infection Antibiotics Ear infection Disease Biochemistry Microbiology Article 03 medical and health sciences 0302 clinical medicine 030225 pediatrics Internal medicine antibiotic medicine pneumonia Pharmacology (medical) 030212 general & internal medicine General Pharmacology Toxicology and Pharmaceutics Medical prescription business.industry routine care data pandemic lcsh:RM1-950 COVID-19 medicine.disease Pneumonia lcsh:Therapeutics. Pharmacology Infectious Diseases Infectious disease (medical specialty) International Classification of Primary Care business urinary tract infection |
| Zdroj: | Antibiotics Volume 10 Issue 2 Antibiotics, Vol 10, Iss 196, p 196 (2021) |
| ISSN: | 2079-6382 |
| DOI: | 10.3390/antibiotics10020196 |
| Popis: | In 2020, the COVID-19 pandemic brought dramatic changes in the delivery of primary health care across the world, presumably changing the number of consultations for infectious diseases and antibiotic use. We aimed to assess the impact of the pandemic on infections and antibiotic prescribing in Dutch primary care. All patients included in the routine health care database of the Julius General Practitioners’ Network were followed from March through May 2019 (n = 389,708) and March through May 2020 (n = 405,688). We extracted data on consultations for respiratory/ear, urinary tract, gastrointestinal and skin infections using the International Classification of Primary Care (ICPC) codes. These consultations were combined in disease episodes and linked to antibiotic prescriptions. The numbers of infectious disease episodes (total and those treated with antibiotics), complications, and antibiotic prescription rates (i.e., proportion of episodes treated with antibiotics) were calculated and compared between the study periods in 2019 and 2020. Fewer episodes were observed during the pandemic months than in the same months in 2019 for both the four infectious disease entities and complications such as pneumonia, mastoiditis and pyelonephritis. The largest decline was seen for gastrointestinal infections (relative risk (RR), 0.54 confidence interval (CI), 0.51 to 0.58) and skin infections (RR, 0.71 CI, 0.67 to 0.75). The number of episodes treated with antibiotics declined as well, with the largest decrease seen for respiratory/ear infections (RR, 0.54 CI, 0.52 to 0.58). The antibiotic prescription rate for respiratory/ear infections declined from 21% to 13% (difference −8.0% (CI, −8.8 to −7.2)), yet the prescription rates for other infectious disease entities remained similar or increased slightly. The decreases in primary care infectious disease episodes and antibiotic use were most pronounced in weeks 15–19, mid-COVID-19 wave, after an initial peak in respiratory/ear infection presentation in week 11, the first week of lock-down. In conclusion, our findings indicate that the COVID-19 pandemic has had profound effects on the presentation of infectious disease episodes and antibiotic use in primary care in the Netherlands. Consequently, the number of infectious disease episodes treated with antibiotics decreased. We found no evidence of an increase in complications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|